| PACKAGING TYPE: | 5ml C-box |
| COMPOSITION: | Tigecycline (50mg) |
| FORMULATION: | Injection |
| Description: | TIGASOL Injection contains Tigecycline 50 mg, a broad-spectrum glycylcycline antibiotic used for the treatment of complicated and resistant bacterial infections. It works by inhibiting bacterial protein synthesis, thereby preventing bacterial growth and multiplication. Tigecycline is effective against a wide range of gram-positive, gram-negative, anaerobic, and multidrug-resistant organisms. It is commonly used in hospital and ICU settings for complicated skin and soft tissue infections, intra-abdominal infections, and community-acquired pneumonia where other antibiotics may fail. |
| Side Effects: | Nausea and vomiting (common) Diarrhea Headache Injection site reactions Elevated liver enzymes Rare pancreatitis |
| How to Use: | To be administered by healthcare professionals only Given via IV infusion only (not IM) Initial loading dose followed by maintenance dosing as prescribed Dosage depends on infection severity and clinical condition |
| Precaution: | For hospital/ICU use only Not recommended for routine infections Use cautiously in liver impairment Monitor liver function during therapy Risk of antibiotic resistance with misuse Not for self-administration |
| Product Benefits: | Broad-spectrum coverage including resistant organisms Effective against MDR (multidrug-resistant) bacteria Useful in complicated skin and soft tissue infections Effective in intra-abdominal infections ICU and critical care antibiotic option Alternati |
Frequently Asked Questions
It is used for complicated and resistant bacterial infections.
Yes, it is a reserve antibiotic used for MDR infections.
It is an alternative in resistant or complicated cases, depending on susceptibility.










